Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Illumina’s Market Dominance Faces New Test As Roche Plans 2026 Sequencer Launch
As Roche prepares to intensify competition, CEO Jacob Thaysen says Illumina’s multidimensional performance will keep it ahead.
Nov 14 2025
•
By
Shubham Singh
During its third-quarter earnings call on Oct. 30, Illumina CEO Jacob Thaysen said that competition remains a positive force for the company. Picture Courtesy: Shutterstock
More from Strategy
More from Business